Design Therapeutics Overview
Design Therapeutics Target Price
Analysts' 12-month price predictions for DSGN.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.76
Average Target Price
$20.50
90.5% upside
90.5% upside2 analysts in the last 4 months
High: $21 | Low: $20
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-04 | Oppenheimer | $21 | 95.2% upside |  |
| 2026-04-29 | Piper Sandler | $20 | 85.9% upside | |
| 2026-01-07 | Oppenheimer | $18 | 67.3% upside | |
| 2025-12-03 | Craig-HallumAdam Vogel | $15 | 39.4% upside | |
| 2025-12-03 | Leerink PartnersJoseph Schwartz | $14 | 30.1% upside | |
| 2024-05-07 | Piper SandlerYasmeen Rahimi | $12 | 11.5% upside | |
| 2023-08-15 | RBC CapitalLeonid Timashev | $7 |  34.9% downside | |
| 2022-12-07 | Piper SandlerYasmeen Rahimi | $42 | 290.3% upside | |
| 2022-05-02 | RBC Capital | $30 | 178.8% upside | |
| 2022-01-19 | Goldman SachsMadhu Kumar | $10 | 7.1% downside | |